Envoy Medical has expanded its intellectual property portfolio with four patents granted or pending in Australia and Europe, reinforcing its leadership in fully implanted hearing solutions.

Australian Patent No. 2022227537 (granted July 3, 2025) and European Patent Nos. 4297848 and 4297851 (granted April 8, 2026) cover combination implant systems with removable earplug sensors, signal analysis functionality and rechargeable energy storage. A fourth European Patent No. 4297862 (expected June 10, 2026) focuses on thermal-dose prediction and safety monitoring during rechargeable implant battery charging.

These patents protect key innovations in implant architecture, signal processing and battery recharge safety, strengthening Envoy Medical’s position against competitors and supporting its investigational Acclaim® cochlear implant and commercial Esteem® middle ear implant product lines.